DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
8.33
-0.46 (-5.23%)
At close: Nov 16, 2026, 4:00 PM EST
8.35
+0.02 (0.24%)
After-hours: Nov 16, 2026, 7:30 PM EST

DiaMedica Therapeutics Statistics

Total Valuation

DMAC has a market cap or net worth of $449.47 million. The enterprise value is $414.72 million.

Market Cap449.47M
Enterprise Value 414.72M

Important Dates

The last earnings date was Thursday, November 12, 2026, after market close.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

DMAC has 53.96 million shares outstanding. The number of shares has increased by 20.04% in one year.

Current Share Class 53.96M
Shares Outstanding 53.96M
Shares Change (YoY) +20.04%
Shares Change (QoQ) +0.09%
Owned by Insiders (%) 46.66%
Owned by Institutions (%) 20.72%
Float 25.33M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 15.68
P/TBV Ratio 15.68
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.76, with a Debt / Equity ratio of 0.01.

Current Ratio 4.76
Quick Ratio 4.71
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -100.23% and return on invested capital (ROIC) is -64.76%.

Return on Equity (ROE) -100.23%
Return on Assets (ROA) -56.08%
Return on Invested Capital (ROIC) -64.76%
Return on Capital Employed (ROCE) -145.70%
Weighted Average Cost of Capital (WACC) 9.40%
Revenue Per Employee n/a
Profits Per Employee -$1.15M
Employee Count35
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, DMAC has paid $32,000 in taxes.

Income Tax 32,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +40.47% in the last 52 weeks. The beta is 0.94, so DMAC's price volatility has been similar to the market average.

Beta (5Y) 0.94
52-Week Price Change +40.47%
50-Day Moving Average 8.24
200-Day Moving Average 7.18
Relative Strength Index (RSI) 43.95
Average Volume (20 Days) 211,596

Short Selling Information

The latest short interest is 5.02 million, so 9.30% of the outstanding shares have been sold short.

Short Interest 5.02M
Short Previous Month 5.24M
Short % of Shares Out 9.30%
Short % of Float 19.81%
Short Ratio (days to cover) 22.25

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -41.81M
Pretax Income -40.20M
Net Income -40.23M
EBITDA -41.77M
EBIT -41.81M
Earnings Per Share (EPS) -$0.75
Full Income Statement

Balance Sheet

The company has $34.91 million in cash and $157,000 in debt, with a net cash position of $34.75 million or $0.64 per share.

Cash & Cash Equivalents 34.91M
Total Debt 157,000
Net Cash 34.75M
Net Cash Per Share $0.64
Equity (Book Value) 28.66M
Book Value Per Share 0.53
Working Capital 28.04M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.79 million and capital expenditures -$27,000, giving a free cash flow of -$33.82 million.

Operating Cash Flow -33.79M
Capital Expenditures -27,000
Depreciation & Amortization 46,000
Net Borrowing -10,000
Free Cash Flow -33.82M
FCF Per Share -$0.63
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

DMAC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -20.04%
Shareholder Yield -20.04%
Earnings Yield -9.03%
FCF Yield -7.52%

Analyst Forecast

The average price target for DMAC is $16.25, which is 95.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target $16.25
Price Target Difference 95.08%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on November 15, 2018. It was a reverse split with a ratio of 1:20.

Last Split Date Nov 15, 2018
Split Type Reverse
Split Ratio 1:20

Scores

Altman Z-Score n/a
Piotroski F-Score 1